Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P08908 (
5-HT1A
)
5,574
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Brain-derived neurotrophic factor (BDNF) and serotonin
5-HT1A
receptors are implicated in the pathophysiology of depression and the mechanism of action of antidepressant drugs. Here, we explore possible reciprocal interactions of
5-HT1A
receptor knockout and the expression of BDNF, its receptor TrkB and downstream mitogen-activated protein kinase (MAPK) in the ventral (
VHP
) and dorsal hippocampus (DHP). We compared female and male double mutant mice (
5-HT1A
(-/-)/BDNF(+/-)) with single mutant mice (
5-HT1A
(-/-), BDNF(+/-)) and wildtype (WT) controls. Protein expression of BDNF, TrkB, phosphorylation of TrkB (pTrkB) and MAPKs (ERK1, ERK2) was examined using Western blot analysis (n=5-7). As expected, the BDNF(+/-) mice showed ~50% BDNF reduction. Loss of
5-HT1A
receptors induced a significant decrease in BDNF levels in the
VHP
in female mice. The pTrkB/TrkB ratio was also significantly decreased in female
5-HT1A
(-/-) mice and
5-HT1A
(-/-)/BDNF(+/-) mice but not in males. Despite markedly reduced BDNF levels in BDNF(+/-) mice and double mutants, ERK1 activation was unchanged in the female mice. In contrast, ERK2 activation was significantly elevated in the
VHP
of female BDNF(+/-) mice and double mutants. Given the greater vulnerability of women to develop depression and the role of the
VHP
in stress responses and anxiety-related behaviours, our results may shed more light on sex differences in depression and other psychiatric disorders with BDNF and
5-HT1A
receptor dysfunction.
...
PMID:Sex-specific and region-specific changes in BDNF-TrkB signalling in the hippocampus of 5-HT1A receptor and BDNF single and double mutant mice. 2246 83